RapidAI Celebrates International Adoption of AI-Powered Stroke Care with Nearly 300% Growth
Summary
SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the leader in advanced imaging for stroke, today announced unprecedented growth in the adoption and use of the Rapid platform around the world. “The number of people who suffer a stroke worldwide each year is staggering, over fifteen million,” offered Marc Hofmans RapidAI Senior Vice President of Sales, EMEA. This ensures accurate therapeutic intervention in the shortest possible time after the onset of stroke.” Rapid is the only clinically validated platform available and considered by many to be the gold standard for advanced cerebrovascular imaging. RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients using clinically-proven, data-driven technology. With our validated, trusted products developed by medical experts, clinicians worldwide are improving patient care and outcomes every day.